Objectives This study introduces a method to calculate myocardium blood flow (MBF) and coronary flow reserve (CFR) using the relatively low-dose dynamic 320-row multi-detector computed tomography (MDCT), validates the method against 15 O-H 2 O positron-emission tomography (PET) and assesses the CFRs of coronary artery disease (CAD) patients. Methods Thirty-two subjects underwent both dynamic CT perfusion (CTP) and PET perfusion imaging at rest and during pharmacological stress. In 12 normal subjects (pilot group), the calculation method for MBF and CFR was established. In the other 13 normal subjects (validation group), MBF and CFR obtained by dynamic CTP and PET were compared. Finally, the CFRs obtained by dynamic CTP and PET were compared between the validation group and CAD patients (n=7).
Introduction
Cardiac computed tomography angiography (CCTA) provides morphological information concerning coronary artery stenosis with high sensitivity and negative predictive value [1] , but the degree of coronary obstruction assessed by CCTA remains a modest predictor of functional myocardial ischemia [2] .
Measurements of myocardial blood flow (MBF) and coronary flow reserve (CFR) have been reported to be superior for evaluating the physiological significance of coronary lesions [3] . In patients with coronary artery disease (CAD), the reduction in CFR is proportional to the severity of myocardial ischemia [3] . Camici et al. reported that CFR reflects the ability of microvasculature to respond to stimuli and presumably small vessel function [3] . Even patients with angiographically normal arteries sometimes exhibit microvascular dysfunction and low CFR. CFR may therefore be useful for predicting flow-limiting disease [4] . Previous studies have reported that a CFR less than 2.0 reflects severe coronary artery stenosis, physiological myocardial ischemia and microcirculatory dysfunction [5] [6] [7] [8] . On the other hand, Kawata et al. reported that a CFR less than 2.5 is useful for predicting outcome or microcirculatory dysfunction [9] .
The extraction fractions of major tracers such as ammonia and rubidium for quantitative MBF and CFR assessment are lower than that of 15 O-H 2 O PET [10] . 15 O-H 2 O positronemission tomography (PET) is the gold standard tracer because it employs a freely diffusible tracer with 100 % extraction fraction even at high blood flow [10] . However, its clinical use is limited because a cyclotron is required and morphological coronary artery imaging is impossible.
CT perfusion (CTP) combined with coronary CCTA (CTP/ CCTA) shows promise for the accurate detection of obstructive atherosclerosis causing myocardial ischemia [11, 12] . CTP/CCTA provides self-registered data sets permitting direct correlation of stenosis with downstream perfusion deficits [13] [14] [15] . Quantitative dynamic CTP requires data for several cardiac cycles, resulting in a high radiation dose. Given recent advances in multi-detector computed tomography (MDCT) technology [16] , we considered that the second-generation 320-row MDCT system might permit quantitative, relatively low-dose, whole MBF measurement in a single heartbeat without significant artefacts.
The present study was conducted to establish a method for calculating whole MBF and CFR using the relatively lowdose dynamic 320-row MDCT (MBF CT , CFR CT ), with validation against 15 O-H 2 O PET (MBF PET , CFR PET ) as the gold standard, and to compare CFRs in normal subjects and patients with CAD.
Materials and methods

Subjects
This study was prospective. Our institutional review board approved this study from August to December 2012. Written informed consent was obtained from all subjects.
Thirty volunteers (31-60 years old), with no history, family history, symptoms or clinical evidence of CAD (2 eventually excluded because the MDCT protocol was not completed) and 4 patients with symptoms or risk factors of CAD were recruited. A normal group without significant coronary stenosis (<50 %) and a CAD group with significant coronary stenosis (≥50 %) were identified on the basis of CCTA during rest dynamic CTP (25 of the 28 volunteers were in the normal group, 3 volunteers and all 4 patients were in the CAD group). All 32 subjects (25 volunteers and 7 patients, 27 men and 5 women, 47.8±9.5 years old) ( Fig. 1 ) underwent both MDCT and 15 O-H 2 O PET perfusion imaging at rest and with adenosine triphosphate (ATP) stress within a 2-week period.
The normal group was randomized into a pilot group (11 men and 1 woman) to establish the MBF CT calculation method and a validation group (11 men and 2 women) for validation of MBF CT and CFR CT against PET.
Subject preparation
All subjects refrained from drinking caffeinated beverages for at least 24 h, eating for more than 6 h and smoking for at least 4 h before MDCT or PET [17] .
The blood pressure (BP), heart rate (HR) and electrocardiogram (ECG) were monitored during examinations. The ratepressure product (RPP) was calculated as systolic BP×HR. The per cent change in HR induced by ATP was also calculated.
MDCT scanning
Dynamic CTP/CCTA examinations were performed using a second-generation 320-row MDCT system (Aquilion ONE, ViSION Edition, Toshiba Medical Systems, Otawara, Japan). Preliminary phantom studies were conducted to determine the relationship between the dose of iodinated contrast medium (Iohexol, 350 mg I/ml, Daiichi Sankyo, Tokyo) and CT attenuation.
The MDCT examination protocol is shown in Fig. 2a . Stress dynamic CTP with intravenous ATP infusion (0.016 mg/kg/min) was followed by rest dynamic CTP. For each dynamic CTP examination, 50 ml of contrast medium followed by a 30-ml saline chaser was infused at 5 ml/s using a dual-head power injector. A bolus-tracking technique with real-time image reconstruction was used, with the region of interest (ROI) set in the pulmonary artery trunk and a threshold of 100 HU. After a 5-s delay, dynamic CTP images were acquired for 25 s using the ECG monitoring for prospective Fig. 1 Enrolment of subjects. Two volunteers out of 34 subjects were excluded because MDCT protocol was not fully completed. Therefore, a total 32 of subjects were enrolled and divided into three groups: normal pilot (n=12), normal validation (n=13) and coronary artery disease (CAD) (n=7) triggering with a phase window of only 70-80 % of the R-R interval, not continuous. For dynamic images, tube voltage = 80 kV, tube current = 120 mA and gantry rotation time = 275 ms were used. Images were reconstructed at 1-mm intervals using Adaptive Iterative Dose Reduction 3D (AIDR 3D) and beam-hardening correction. The AIDR 3D algorithm works in both the raw and reconstruction image domains [18] . The system provided four strength levels (Weak, Mild, Standard and Strong). We used the AIDR 3D Strong level, which is the strongest setting of AIDR 3D algorithms.
Rest CCTA imaging was performed as a boost scan during rest dynamic CTP, with tube voltage = 80 kV and tube current = 650 mA (for body mass index (BMI)<22.5) or 800 mA (for BMI≥22.5) at 75 % of the R-R interval with 0.5-mm reconstruction. The boost timing was the peak enhancement time of the left main coronary trunk in stress dynamic CTP. 15 O-H 2 O PET imaging 15 O-H 2 O PET examinations were performed as shown in Fig. 2b without ECG gating (ECAT EXACT HR+, Siemens/ CTI, Knoxville, TN) [19] . After attenuation correction, rest and stress examinations (same ATP dose as for CTP) were performed. For each image, 1,500 MBq of 15 O-H 2 O was administered intravenously at 2 min at rest, with 20 frames dynamic PET acquisition initiated over 6 min. 15 O-H 2 O images were acquired in 2D mode with septa extended.
CCTA evaluation
Volume-rendered images, curved multiplanar reformations, maximum intensity projections and cross-sectional images were reconstructed from CT angiographic images at a dedicated workstation (Ziostation 2 plus, Ziosoft, Tokyo). All images were visually assessed for stenosis grade in 17 segments [20] and image quality was scored as follows: 4 = excellent (no artefacts), 3 = good (minor artefacts, good diagnostic quality), 2 = adequate (moderate artefacts, acceptable and diagnostic), 1 = poor (severe artefacts impairing accurate evaluation). All assessments were conducted independently by two physicians blinded to all other clinical data, with discrepancies resolved by consensus.
Quantification of MBF PET
See "Appendix".
Dynamic CTP image reconstruction and MBF CT formula
Radiation dose calculations
CT radiation doses were estimated using the dose-length product reported by the system, with conversion to effective dose by multiplying by a constant (k=0.014 mSv/mGy/cm) according to the European Guidelines on Quality Criteria for CT [21] .
Statistical analysis
All data are expressed as mean±SD. The backgrounds of the normal pilot and validation groups were compared using the Student's t test for age and BMI, whereas Fisher's exact tests Fig. 2 Flow chart of image acquisition methods. a MDCT imaging protocol: First, the stress dynamic computed tomography perfusion (CTP) imaging was performed during the intravenous infusion of adenosine triphosphate (ATP) (0.016 mg/kg/min) under the continuous ECG monitoring. Three minutes after starting the ATP infusion, 50 ml of iodine contrast media was infused at a flow rate of 5 ml/s using a dual-head power injector, followed by 30 ml saline chaser at the same rate. ATP infusion had been continued until the stress dynamic CTP examination was finished. Second, the rest dynamic CTP/cardiac computed tomography angiography (CCTA) imaging was performed at least 15 min after the stress dynamic CTP. We used an intravenous administration of propranolol (up to 10 mg) if the HR for rest CCTA was greater than 65 beats per minutes (bpm were used for gender and smoking. RPP at rest and % change in HR induced by ATP were compared between dynamic CTP and PET using paired t tests.
For comparison of MBF and CFR between dynamic CTP and PET, paired t tests, Pearson's correlation coefficients and linear regression analyses (with Bland-Altman plots) were used. CFRs were compared between the validation and CAD groups using the t test. In addition, receiver operating characteristic (ROC) analysis for detection of CAD was conducted.
Values of P less than 0.05 were considered statistically was used for data analysis.
Results
Subject characteristics
There were no significant differences in age (46. Table 2 ). There were no significant differences in baseline RPP or % change in HR between the two modalities in the validation and CAD groups (P=0.585, P=0.266 in the validation group and P=0.895, P=0.370 in the CAD group respectively).
Formula for computation of MBF CT using Renkin-Crone model
The phantom study showed a linear relationship between the contrast medium dose and CT attenuation. The relationship between contrast concentration (x) (mg I/ml) and CT attenuation (HU) (y) was
Sample time-attenuation curves (TACs) from the pilot group after subtraction of the first frame from all subsequent frames (both rest and stress) are shown in Fig. 3 . These TACs were converted to contrast concentrations using Eq. (1).
Rest and stress K1 CT values in the pilot group were 0.58± 0.13 and 1.24±0.17 ml/min/g respectively, and rest and stress MBF PET values were 0.72±0.17 and 3.23±0.73 ml/min/g respectively. From these data, parameters α (0.904) and β (1.203) were estimated using Eqs. (3)- (8) in the "Appendix". The Renkin-Crone formula between K1 CT and MBF CT was expressed as
This equation was used to calculate MBF CT in the validation and CAD groups using each subject's K1 CT .
Validation of MBF CT against 15 
O-H 2 O PET
In the validation group, Pearson's correlation coefficients and linear regression analyses of MBF showed good correlations (r = 0.95, P < 0.0001) between dynamic CTP and PET (Fig. 4a) , but there was a small bias suggesting that MBF CT tended to scatter at high flow seen on the Bland-Altman plot (Fig. 4b ). There were no significant differences in rest and stress MBF between dynamic CTP and PET in the validation and CAD groups (for rest P=0.831, for stress P=0.757 in the validation group, and P=0.050, P=0.076 in the CAD group respectively). Stress MBF was significantly higher than rest MBF for dynamic CTP and PET (for dynamic CTP P=0.003, for PET P=0.001 in the validation group and P<0.0001, P<0.0001 in the CAD group respectively), except for one normal subject in the validation group whose MBF did not increase in the stress study despite refraining from caffeine, smoking and eating.
Validation and comparison of CFR between the validation and the CAD groups A moderate correlation was observed in CFR between dynamic CTP and PET in the validation group (r=0.67, P= 0.0126) (Fig. 5) . CFR CT in the CAD group (2.3±0.8) was significantly lower than in the validation group (5.2±1.8) (P= 0.0011) (Fig. 6) . CFR PET in the CAD group (2.6±1.1) was also significantly lower than in the validation group (5.0±1.6) (P=0.0011). There were no significant differences between CFR CT and CFR PET in the validation and CAD groups (for validation group P = 0.81, for CAD group P =0.65 respectively). CAD coronary artery disease, CTP computed tomography perfusion, sBP systolic blood pressure, HR heart rate, RPP rate pressure product, % change per cent changes in HR before and after adenosine triphosphate infusion In the ROC analysis of CFR CT for detection of CAD, the area under the curve of the ROC was 0.90 (P=0.0043). The sensitivity was 85.7 % and specificity was 92.3 %, when a cutoff of 2.97 was used for detection of CAD.
CCTA image quality
The average image quality score was 3.8±0.1 for all coronary arteries in all subjects. Only 7 coronary segments (1.6 %) were under score 2 and most coronary segments could be assessed for stenosis (98.4 %). Seventeen coronary segments in 7 patients showed ≥50 % stenosis. Five subjects had onevessel disease, one had two-vessel disease and one had three-vessel disease. Curved multiplanar reformation of CCTA and dynamic CTP images (stress and rest status) of a CAD patient (BMI 27.7) are shown in Fig. 7 . In the CCTA image, the image quality of the patient was excellent and the severe stenosis (70-99 %) in the proximal of left anterior descending artery (LAD) was well demonstrated. In the left Fig. 6 Comparison between the validation group with no coronary artery stenosis and the coronary artery disease group with coronary artery stenosis for each CFR CT and CFR PET . The black circle is CFR PET and the black triangle is CFR CT . There are no significant differences between CFR CT and CFR PET in each validation and coronary artery disease (CAD) group. Both CFR CT (2.3±0.8) and CFR PET (2.6±1.1) in the CAD group are significantly lower than those (5.2±1.8, 5.0±1.6, respectively) in the validation group (P=0.0011 and P=0.0011, respectively) Fig. 7 Example of cardiac computed tomography angiography (CCTA) image taken during rest dynamic CT perfusion (CTP) image. The patient was a 43-year-old man and his BMI was 27.7. Curved planar reconstruction of a the left anterior descending artery (LAD). The image quality of CCTA was excellent and the severe stenosis (70-99 %) of the proximal of the LAD is clearly demonstrated (arrowhead). In the stress dynamic CTP status, CT attenuation in the anterior wall (LAD territory) was decreased (b). On the other hand, the CT attenuation in the same area was normal in the rest dynamic CTP (c). Both his CFR CT and CFR PET (2.52 and 2.08) were decreased. Note that there was no beam-hardening or banding artefact of the dynamic CTP ventricular short axis images of CTP, CT attenuation in the anterior wall (LAD territory) was decreased in the stress CTP.
Radiation dose
The average total dose for CT studies was 12.8±2.9 mSv for all subjects; for PET studies it was 3.3 mSv as reported in our previous study [22] .
Discussion
This study introduced and validated the method for whole MBF and CFR with the relatively low-dose dynamic 320-row MDCT in comparison with 15 O-H 2 O PET. Our preliminary results showed that the MBF CT and CFR CT were well correlated with 15 O-H 2 O PET and lower CFR was demonstrated in CAD patients compared to normal controls.
It has been hypothesized that combining CCTA and dynamic CTP may avoid the limitations of CCTA, allowing the diagnosis of cardiac ischemia with accurate anatomic assessment in one examination. Bettencourt et al. reported that integrating CTP/CCTA improved MDCT performance in detecting clinically significant CAD in intermediate to high pretest probability populations [11] . However, few established protocols have combined stress and rest CTP and CCTA due to the high radiation dose. In addition, incomplete heart coverage as well as motion, beam-hardening and banding artefacts reduce the accuracy and reproducibility of MBF calculations with 64-row MDCT [16] . Huber et al. reported that the radiation dose in dynamic CTP for 25 s with 256-row CT was 9.5 mSv, but only for stress dynamic CTP, and they could not calculate CFR [23] . Fujita et al. reported that they could obtain images without compromising image quality or stress MBF and could also allow 40 % dose reduction using 80 kV instead of 100 kV [24] . However, they only looked at stress dynamic CTP, did not calculate CFR, and their CT coverage was not enough to capture the whole heart within one beat. In the present study, with the relatively low-dose dynamic CTP in rest and stress states using the second-generation 320-row MDCT, we examined at 80 kV instead of 120 kV (as used in a previous study with the first-generation 320-row MDCT [25] ). The average total radiation dose was therefore 12.8 mSv, about half the previous value of 25.5 mSv [25] . At 80 kV, there was no beam-hardening or banding artefact with our protocol, both dynamic LV blood and myocardial TACs were successfully obtained, as well as rest CCTA data like recently reported [26] . The images of rest CCTA during dynamic CTP (HR=61±8 bpm) were quite good, sufficient for evaluation (average score = 3.8, 98.4 % of segments assessable) [27] . We used the second-generation 320-row MDCT (gantry rotation time = 275 ms, iterative reconstruction AIDR 3D), which allowed for the insertion of a higher boost image (80 kV, 800 mA) for CCTA during dynamic perfusion scan (80 kV, 120 mA), and resulted in less motion artefacts and a combination of dynamic CTP and CCTA data with relatively low radiation dose [28, 29] .
We calculated the MBF CT and CFR CT from the relatively low-dose dynamic CTP, which showed good correlation with 15 O-H 2 O PET. 15 O-H 2 O PET is a gold standard for a quantitative assessment of the MBF, as it is the only method with a freely diffusible tracer with 100 % extraction fraction even at increased blood flows [10] . The extraction fractions in other tracers are lower than in 15 O-H 2 O PET [10] . This study was the first in which MBF and CFR calculated from dynamic CTP were validated by 15 O-H 2 O PET. CFR has been used as a sensitive marker of high-risk anatomic coronary artery disease in a PET study [30] , but PET cannot provide coronary morphological information with MBF and CFR simultaneously. Our 320-row MDCT comprehensive protocol provides quantitative MBF and CFR together with morphological information. Clinically, CFR CT may help in evaluating the functional severity of CAD, especially with severe calcification, which interferes with CCTA evaluation [1] . CFR CT values in CAD patients were significantly lower than in normal controls in this study. In addition, the sensitivity was 85.7 % and specificity was 92.3 % at a cut-off value of 2.97 for detection of CAD. CFR cut-off values have generally been 2.0 or 2.5, scores found useful for predicting outcome or microcirculatory dysfunction [5] [6] [7] [8] [9] .
Our method, employing both K1 and k2, is more complicated than the Patlak plot and upslope methods, which do not consider k2 (the outflow rate from LV myocardium into the LV chamber) and do not require the entire TAC [31, 32] . MBF values are systematically underestimated, especially at high flow with the Patlak plot and upslope methods [31, 32] . Therefore, our method using K1 and k2 is more physiologic for calculating MBF.
In this study, there was a small bias suggesting that MBF CT tended to scatter at high flow during stress as compared to PET. This may have been due to different reactions to pharmacological stress in individual subjects. However, the correlations of MBF and CFR between the two modalities were quite high, indicating that MBF CT and CFR CT are reliable indicators.
This study has several limitations. First, the order of rest and stress examinations differed between the two modalities. Stress dynamic CTP was performed before rest dynamic CTP/ CCTA because rest dynamic CTP/CCTA requires the preimaging administration of nitrates and/or beta-blockers, which might mask myocardial ischemia in subsequent stress dynamic CTP. In addition, the optimal boost timing for rest CCTA was determined using stress dynamic CTP data. Therefore, the timing of boosted CCTA during rest dynamic CTP was good and resulted in good image quality. On the other hand, PET examinations were performed in the opposite order to save time. We think that this did not significantly affect the results, because the RPPs were not significantly different between the two modalities and a previous study reported no effects on MBF PET with different examination orders [33] . In addition, we subtracted the first frame from all subsequent frames in both stress and rest dynamic CTP, so the residual contrast from the stress examination would not affect the subsequent rest examination.
Second, only the whole MBF, not regional the MBF, was calculated. In general, whole MBF and CFR are of utility in relatively limited populations. In addition, it would be possible to match the culprit site of CCTA with the ischemic lesion of CTP by calculating the regional MBF. However, this is a preliminary study and the study showed the potential for detecting myocardial ischemia using only MDCT. In this study, regional MBF cannot be obtained because of unstable curve fitting for estimating K1 and higher noise in the relatively low-dose dynamic CTP. More effective noise reduction using iterative image reconstruction or other techniques may allow assessment of regional MBF.
Third, the number of patients used to test the diagnostic value of CAD by CFR was very small, because the main purpose of the current study was to validate this dynamic CTP method in comparison to the well-documented 15 O-H 2 O PET technique. Another study is warranted to confirm the diagnostic value of dynamic CTP with this model in a data set with many more patients.
Finally, overweight or female subjects were not included in this study, which may have resulted in an under-or overestimation of the radiation dose that would normally be seen in a typical patient population including female or overweight to obese subjects.
In conclusion, we have established a method for calculating whole MBF and CFR using relatively low-dose dynamic CTP imaging with 320-row MDCT with validation against This model is consistent with the observation that tracer or contrast media extraction typically decreases with flow, despite the PS product increasing owing to capillary recruitment. The PS function is typically presented as
Using Eqs. (4), (5) and (6), the Renkin-Crone model was expressed as
where α is exp(−A). Parameters α and β were estimated from the data for the pilot group. Then, MBF CT values in the validation and CAD groups were calculated using Eq. (7) based on K1 CT and estimated α and β.
CFR was also calculated as the ratio of stress MBF to rest MBF [3, 27] .
